XBI
XBI
About State Street SPDR S&P Biotech ETF
The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index...
About State Street SPDR S&P Biotech ETF
The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 TVTX | Travere Therapeutics, Inc. | 1.83% | 3.19M | $151.05M |
 RVMD | Revolution Medicines, Inc. | 1.76% | 947.32K | $145.29M |
 TWST | Twist Bioscience Corporation | 1.67% | 2.01M | $137.87M |
 ALKS | Alkermes plc | 1.63% | 3.40M | $134.60M |
 TGTX | TG Therapeutics, Inc. | 1.56% | 3.36M | $129.51M |
 ARWR | Arrowhead Pharmaceuticals, Inc. | 1.54% | 1.62M | $127.33M |
 BEAM | Beam Therapeutics Inc. | 1.42% | 3.62M | $117.71M |
 EXEL | Exelixis, Inc. | 1.39% | 2.26M | $115.33M |
 KRYS | Krystal Biotech, Inc. | 1.38% | 370.03K | $113.89M |
 NBIX | Neurocrine Biosciences, Inc. | 1.36% | 728.32K | $112.97M |
 CYTK | Cytokinetics, Incorporated | 1.36% | 1.48M | $112.97M |
 MDGL | Madrigal Pharmaceuticals, Inc. | 1.35% | 218.68K | $111.91M |
 PRAX | Praxis Precision Medicines, Inc. | 1.34% | 317.76K | $111.14M |
 SRRK | Scholar Rock Holding Corporation | 1.30% | 2.19M | $107.98M |
 CELC | Celcuity Inc. | 1.28% | 815.07K | $105.83M |
 CRSP | CRISPR Therapeutics AG | 1.28% | 1.89M | $105.69M |
 VCYT | Veracyte, Inc. | 1.25% | 2.18M | $103.78M |
 NUVL | Nuvalent, Inc. | 1.24% | 943.18K | $102.22M |
 NTRA | Natera, Inc. | 1.23% | 479.88K | $101.83M |
 MIRM | Mirum Pharmaceuticals, Inc. | 1.23% | 1.03M | $101.59M |
SECTOR HOLDINGS
Healthcare
Financial ServicesASSET ALLOCATION BY REGION
United States
Ireland
Switzerland
United Kingdom
NetherlandsSECTOR HOLDINGS
Healthcare Financial ServicesASSET ALLOCATION BY REGION
United States Ireland Switzerland United Kingdom NetherlandsHoldings (Top 20)
TVTX
Travere Therapeutics, Inc.
RVMD
Revolution Medicines, Inc.
TWST
Twist Bioscience Corporation
ALKS
Alkermes plc
TGTX
TG Therapeutics, Inc.
ARWR
Arrowhead Pharmaceuticals, Inc.
BEAM
Beam Therapeutics Inc.
EXEL
Exelixis, Inc.
KRYS
Krystal Biotech, Inc.
NBIX
Neurocrine Biosciences, Inc.
CYTK
Cytokinetics, Incorporated
MDGL
Madrigal Pharmaceuticals, Inc.
PRAX
Praxis Precision Medicines, Inc.
SRRK
Scholar Rock Holding Corporation
CELC
Celcuity Inc.
CRSP
CRISPR Therapeutics AG
VCYT
Veracyte, Inc.
NUVL
Nuvalent, Inc.
NTRA
Natera, Inc.
MIRM
Mirum Pharmaceuticals, Inc.